Institutional investors control 9.59% of the outstanding shares in GSK. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended June 2017, these large investors purchased a net $10.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RENAISSANCE TECHNOLOGIES LLC Bought 4.9 Million shares of GlaxoSmithKline
T. ROWE PRICE ASSOCIATES, INC. Bought 2.8 Million shares of GlaxoSmithKline
MILLENNIUM MANAGEMENT LLC Bought 2.3 Million shares of GlaxoSmithKline